Category: Baxano Surgical
Here's a look at some of the top Wall Street stories for medical device companies this week: FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried; Greatbatch acquires Uruguay's CCC Medical Devices; T2 Biosystems IPO raises $57M for MRI-based diagnostics; Strong Q4, $750M buyback give CareFusion a boost; Baxano: Strong Q2, new patents can't appease Wall Street
Baxano's stock drops 25% after the company reports a 20% increase in sales during its 2nd quarter and the issuance of 2 new patents covering its minimally invasive spinal devices.
Baxano Surgical (NSDQ:BAXS) just can't seem to do right by Wall Street.
Here's a look at some of the top funding stories for medical device companies this week.
Baxano Surgical puts a ribbon on a private placement funding round after raising $10 million from unnamed investors.
SafeStitch Medical lures Joseph Slattery to be its new CFO from Baxano, who names former Talecris Biotherapeutics exec Timothy Shannon as interim replacement.
Baxano fails to meet Wall Streets expectations during its 2nd quarter of 2013, during which the company reinvented itself as Baxano Surgical.
Baxano Surgical closes the books, without admitting wrong-doing, on a Justice Dept. investigation over allegations of healthcare fraud.